Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled…

Overview of attention for article published in British Journal of Dermatology, August 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 14 news stories from 14 outlets.

For people with skin diseases such as atopic dermatitis (eczema), psoriasis, and acne, symptoms such as itchiness and…

Researchers found a significant improvement in the sleep quality numeric rating scale in dupilumab-treated patients vs those…

For adults with moderate-to-severe atopic dermatitis (AD), dupilumab treatment yields significant improvement in sleep quality…

For adults with moderate-to-severe atopic dermatitis (AD), dupilumab treatment yields significant improvement in sleep quality…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 10 additional news stories.